HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FZD5
frizzled class receptor 5
Chromosome 2 Β· 2q33.3
NCBI Gene: 7855Ensembl: ENSG00000163251.5HGNC: HGNC:4043UniProt: Q13467
87PubMed Papers
21Diseases
1Drugs
9Pathogenic Variants
FUNCTIONAL ROLE
Receptor
CLINICAL
Early PipelineOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
eye developmentamyloid-beta bindingprotein bindingWnt-protein bindingmicrophthalmia/coloboma 11colobomacoloboma of optic nervecoloboma of iris
✦AI Summary

FZD5 (frizzled class receptor 5) functions as a critical Wnt protein receptor that mediates both canonical and non-canonical Wnt signaling pathways across multiple tissues. FZD5 serves as an essential regulator of intestinal homeostasis, where epithelial-specific knockout results in lethal pan-intestinal crypt and villus loss, and depletion specifically in Lgr5+ intestinal stem cells causes premature differentiation 1. The receptor undergoes Wnt-induced endocytosis and degradation through ZNRF3/RNF43-mediated mechanisms, representing a negative regulatory feedback loop 2. In cardiovascular disease, FZD5 mediates cardiac fibrosis through crosstalk with EGFR signaling in response to Wnt5a and Wnt11 under pressure overload conditions 3. FZD5 also plays important roles in angiogenesis, where it mediates VEGF-independent angiogenesis through Wnt5a/FZD5/NF-ΞΊB/ERK signaling in breast cancer 4. Additionally, FZD5 contributes to hepatic metabolism by controlling cholesterol uptake and bile acid conjugation in hepatocytes via WNT2 signaling 5, and participates in pulmonary epithelial metaplasia through sFRP2-mediated non-canonical Wnt signaling 6. The receptor shows primate-specific expression patterns during early gastrulation 7 and responds to engineered Wnt surrogate agonists 8.

Sources cited
1
FZD5 is essential for intestinal homeostasis and Lgr5+ stem cell maintenance
PMID: 39579768
2
FZD5 undergoes Wnt-induced endocytosis and degradation via ZNRF3/RNF43
PMID: 39463927
3
FZD5 mediates cardiac fibrosis through crosstalk with EGFR signaling
PMID: 34564708
4
FZD5 mediates VEGF-independent angiogenesis through Wnt5a signaling
PMID: 33754039
5
FZD5 controls hepatic cholesterol uptake and bile acid conjugation
PMID: 37562401
6
FZD5 participates in pulmonary epithelial metaplasia via sFRP2 signaling
PMID: 38980870
7
FZD5 shows primate-specific expression during gastrulation
PMID: 35709828
8
FZD5 responds to engineered Wnt surrogate agonists
PMID: 28467818
Disease Associationsβ“˜21
microphthalmia/coloboma 11Open Targets
0.67Moderate
colobomaOpen Targets
0.55Moderate
coloboma of optic nerveOpen Targets
0.37Weak
coloboma of choroid and retinaOpen Targets
0.37Weak
coloboma of eye lensOpen Targets
0.37Weak
coloboma of eyelidOpen Targets
0.37Weak
coloboma of irisOpen Targets
0.37Weak
coloboma of maculaOpen Targets
0.37Weak
Coloboma of optic papillaOpen Targets
0.37Weak
neurodegenerative diseaseOpen Targets
0.37Weak
pancreatic carcinomaOpen Targets
0.25Weak
genetic disorderOpen Targets
0.19Weak
obesityOpen Targets
0.12Weak
bladder exstrophyOpen Targets
0.11Weak
prostate cancerOpen Targets
0.08Suggestive
hepatocellular carcinomaOpen Targets
0.08Suggestive
Ovarian cystOpen Targets
0.07Suggestive
non-small cell lung carcinomaOpen Targets
0.06Suggestive
neoplasmOpen Targets
0.06Suggestive
breast cancerOpen Targets
0.05Suggestive
Microphthalmia/Coloboma 11UniProt
Pathogenic Variants9
NM_003468.4(FZD5):c.986G>T (p.Ser329Ile)Likely pathogenic
Microphthalmia/coloboma 11
β˜…β˜†β˜†β˜†2026β†’ Residue 329
NM_003468.4(FZD5):c.1146del (p.Asp382fs)Likely pathogenic
Congenital ocular coloboma
β˜…β˜†β˜†β˜†2024β†’ Residue 382
NM_003468.4(FZD5):c.1081_1082insGAA (p.His361delinsArgAsn)Likely pathogenic
Congenital ocular coloboma
β˜…β˜†β˜†β˜†2019β†’ Residue 361
NM_003468.4(FZD5):c.1181_1246del (p.Asn394_Gly415del)Likely pathogenic
Congenital ocular coloboma|Microphthalmia/coloboma 11
β˜…β˜†β˜†β˜†2019β†’ Residue 394
NM_003468.4(FZD5):c.830del (p.Cys277fs)Pathogenic
Microphthalmia/coloboma 11
β˜†β˜†β˜†β˜†2024β†’ Residue 277
NM_003468.4(FZD5):c.656delinsAG (p.Ala219fs)Pathogenic
Microphthalmia/coloboma 11
β˜†β˜†β˜†β˜†2024β†’ Residue 219
NM_003468.4(FZD5):c.1232A>G (p.Tyr411Cys)Pathogenic
Microphthalmia/coloboma 11
β˜†β˜†β˜†β˜†2024β†’ Residue 411
NM_003468.4(FZD5):c.1428del (p.Ser477fs)Pathogenic
Microphthalmia/coloboma 11
β˜†β˜†β˜†β˜†2024β†’ Residue 477
NM_003468.4(FZD5):c.1403_1406dup (p.Tyr470fs)Pathogenic
Microphthalmia/coloboma 11
β˜†β˜†β˜†β˜†2024β†’ Residue 470
View on ClinVar β†—
Drug Targets1
VANTICTUMABPhase I
Frizzled-1 antagonist
Related Genes
ROR1Protein interaction100%ROR2Protein interaction100%AXIN1Protein interaction100%GSK3BProtein interaction98%GPC4Protein interaction97%CAV1Protein interaction97%
Tissue Expression6 tissues
Liver
100%
Lung
24%
Bone Marrow
16%
Ovary
15%
Brain
8%
Heart
6%
Gene Interaction Network
Click a node to explore
FZD5ROR1ROR2AXIN1GSK3BGPC4CAV1
PROTEIN STRUCTURE
Preparing viewer…
PDB6O39 Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.55Moderately Constrained
pLIβ“˜
0.90Intolerant
Observed/Expected LoF0.34 [0.22–0.55]
RankingsWhere FZD5 stands among ~20K protein-coding genes
  • #5,476of 20,598
    Most Researched87
  • #2,948of 5,498
    Most Pathogenic Variants9
  • #3,537of 17,882
    Most Constrained (LOEUF)0.55 Β· top quartile
Genes detectedFZD5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions.
PMID: 37562401
Cell Β· 2023
1.00
2
A fibroblast-dependent TGF-Ξ²1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis.
PMID: 38980870
J Clin Invest Β· 2024
0.90
3
Spatial profiling of early primate gastrulation in utero.
PMID: 35709828
Nature Β· 2022
0.80
4
Surrogate Wnt agonists that phenocopy canonical Wnt and Ξ²-catenin signalling.
PMID: 28467818
Nature Β· 2017
0.70
5
FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts.
PMID: 33754039
Theranostics Β· 2021
0.60